Comparison of stent retriever and intra-arterial fibrinolysis in patients with acute ischaemic stroke

D. Song, Byungmoon Kim, D. J. Kim, Y. D. Kim, J. Kim, H. S. Lee, H. S. Nam, Jihoe Heo

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background and purpose: Although the stent retriever (SR) has shown a better reperfusion rate and clinical outcome than the older generation mechanical clot retrieval device, it is uncertain whether the SR is superior to intra-arterial fibrinolysis (IAF). Methods: Ischaemic stroke patients who were treated with SR or IAF as initial endovascular treatment modality for unilateral arterial occlusion in the anterior circulation were included. Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade ≥2b. A favourable clinical outcome was defined as a modified Rankin Score ≤2 at 3 months. Results: Between January 2009 and May 2012, 55 patients were treated with SR and 50 patients were treated with IAF. The baseline characteristics were similar between the two groups except for the occlusion site and rescue treatment. In binary logistic regression analysis adjusted for the occlusion site and rescue treatment, SR was independently associated with increased successful reperfusion [82.0% vs. 47.3%; odds ratio (OR) 5.21; 95% confidence interval (CI) 1.92-14.14) and a more favourable clinical outcome at 3 months (54.0% vs. 43.6%; OR 3.40; 95% CI 1.31-8.84). The frequency of symptomatic intracranial haemorrhage and mortality at 3 months was not different between the two groups. Conclusions: Stent retriever was as safe as and more effective than IAF. Our findings suggest that SR may be considered as an initial modality rather than IAF in acute stroke patients who undergo endovascular treatment.

Original languageEnglish
Pages (from-to)779-784
Number of pages6
JournalEuropean Journal of Neurology
Volume21
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Fibrinolysis
Stents
Stroke
Reperfusion
Odds Ratio
Confidence Intervals
Intracranial Hemorrhages
Cerebral Infarction
Therapeutics
Logistic Models
Regression Analysis
Equipment and Supplies
Mortality

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Song, D. ; Kim, Byungmoon ; Kim, D. J. ; Kim, Y. D. ; Kim, J. ; Lee, H. S. ; Nam, H. S. ; Heo, Jihoe. / Comparison of stent retriever and intra-arterial fibrinolysis in patients with acute ischaemic stroke. In: European Journal of Neurology. 2014 ; Vol. 21, No. 5. pp. 779-784.
@article{ae166c9b79904731b895f323045b6481,
title = "Comparison of stent retriever and intra-arterial fibrinolysis in patients with acute ischaemic stroke",
abstract = "Background and purpose: Although the stent retriever (SR) has shown a better reperfusion rate and clinical outcome than the older generation mechanical clot retrieval device, it is uncertain whether the SR is superior to intra-arterial fibrinolysis (IAF). Methods: Ischaemic stroke patients who were treated with SR or IAF as initial endovascular treatment modality for unilateral arterial occlusion in the anterior circulation were included. Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade ≥2b. A favourable clinical outcome was defined as a modified Rankin Score ≤2 at 3 months. Results: Between January 2009 and May 2012, 55 patients were treated with SR and 50 patients were treated with IAF. The baseline characteristics were similar between the two groups except for the occlusion site and rescue treatment. In binary logistic regression analysis adjusted for the occlusion site and rescue treatment, SR was independently associated with increased successful reperfusion [82.0{\%} vs. 47.3{\%}; odds ratio (OR) 5.21; 95{\%} confidence interval (CI) 1.92-14.14) and a more favourable clinical outcome at 3 months (54.0{\%} vs. 43.6{\%}; OR 3.40; 95{\%} CI 1.31-8.84). The frequency of symptomatic intracranial haemorrhage and mortality at 3 months was not different between the two groups. Conclusions: Stent retriever was as safe as and more effective than IAF. Our findings suggest that SR may be considered as an initial modality rather than IAF in acute stroke patients who undergo endovascular treatment.",
author = "D. Song and Byungmoon Kim and Kim, {D. J.} and Kim, {Y. D.} and J. Kim and Lee, {H. S.} and Nam, {H. S.} and Jihoe Heo",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/ene.12391",
language = "English",
volume = "21",
pages = "779--784",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "5",

}

Comparison of stent retriever and intra-arterial fibrinolysis in patients with acute ischaemic stroke. / Song, D.; Kim, Byungmoon; Kim, D. J.; Kim, Y. D.; Kim, J.; Lee, H. S.; Nam, H. S.; Heo, Jihoe.

In: European Journal of Neurology, Vol. 21, No. 5, 01.01.2014, p. 779-784.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of stent retriever and intra-arterial fibrinolysis in patients with acute ischaemic stroke

AU - Song, D.

AU - Kim, Byungmoon

AU - Kim, D. J.

AU - Kim, Y. D.

AU - Kim, J.

AU - Lee, H. S.

AU - Nam, H. S.

AU - Heo, Jihoe

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background and purpose: Although the stent retriever (SR) has shown a better reperfusion rate and clinical outcome than the older generation mechanical clot retrieval device, it is uncertain whether the SR is superior to intra-arterial fibrinolysis (IAF). Methods: Ischaemic stroke patients who were treated with SR or IAF as initial endovascular treatment modality for unilateral arterial occlusion in the anterior circulation were included. Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade ≥2b. A favourable clinical outcome was defined as a modified Rankin Score ≤2 at 3 months. Results: Between January 2009 and May 2012, 55 patients were treated with SR and 50 patients were treated with IAF. The baseline characteristics were similar between the two groups except for the occlusion site and rescue treatment. In binary logistic regression analysis adjusted for the occlusion site and rescue treatment, SR was independently associated with increased successful reperfusion [82.0% vs. 47.3%; odds ratio (OR) 5.21; 95% confidence interval (CI) 1.92-14.14) and a more favourable clinical outcome at 3 months (54.0% vs. 43.6%; OR 3.40; 95% CI 1.31-8.84). The frequency of symptomatic intracranial haemorrhage and mortality at 3 months was not different between the two groups. Conclusions: Stent retriever was as safe as and more effective than IAF. Our findings suggest that SR may be considered as an initial modality rather than IAF in acute stroke patients who undergo endovascular treatment.

AB - Background and purpose: Although the stent retriever (SR) has shown a better reperfusion rate and clinical outcome than the older generation mechanical clot retrieval device, it is uncertain whether the SR is superior to intra-arterial fibrinolysis (IAF). Methods: Ischaemic stroke patients who were treated with SR or IAF as initial endovascular treatment modality for unilateral arterial occlusion in the anterior circulation were included. Successful reperfusion was defined as Thrombolysis in Cerebral Infarction grade ≥2b. A favourable clinical outcome was defined as a modified Rankin Score ≤2 at 3 months. Results: Between January 2009 and May 2012, 55 patients were treated with SR and 50 patients were treated with IAF. The baseline characteristics were similar between the two groups except for the occlusion site and rescue treatment. In binary logistic regression analysis adjusted for the occlusion site and rescue treatment, SR was independently associated with increased successful reperfusion [82.0% vs. 47.3%; odds ratio (OR) 5.21; 95% confidence interval (CI) 1.92-14.14) and a more favourable clinical outcome at 3 months (54.0% vs. 43.6%; OR 3.40; 95% CI 1.31-8.84). The frequency of symptomatic intracranial haemorrhage and mortality at 3 months was not different between the two groups. Conclusions: Stent retriever was as safe as and more effective than IAF. Our findings suggest that SR may be considered as an initial modality rather than IAF in acute stroke patients who undergo endovascular treatment.

UR - http://www.scopus.com/inward/record.url?scp=84897964026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897964026&partnerID=8YFLogxK

U2 - 10.1111/ene.12391

DO - 10.1111/ene.12391

M3 - Article

C2 - 24612359

AN - SCOPUS:84897964026

VL - 21

SP - 779

EP - 784

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 5

ER -